Correspondingly, DMPQ significantly reduced the effect of MCM in CL2 only (a 16% decrease, p < 0.05) along with a non-significant reduction in CL1 and CL3, suggesting that PDGFβ could be involved in microglia-driven glioma cell viability. The gene discussed is PDGFB; the disease is central nervous system cancer.